Eva Dokoupilová, David Vetchý, Sylvie Pavloková, & Markéta Hanuštiaková. (2024). Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers. Elsevier.
Čikaški stil citiranja (17. izdanje)Eva Dokoupilová, David Vetchý, Sylvie Pavloková, i Markéta Hanuštiaková. Effect of Treatment with Original or Biosimilar Adalimumab on SARS-CoV2 Vaccination Antibody Titers. Elsevier, 2024.
MLA način citiranja (9. izdanje)Eva Dokoupilová, et al. Effect of Treatment with Original or Biosimilar Adalimumab on SARS-CoV2 Vaccination Antibody Titers. Elsevier, 2024.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.